Sign in
4

Changes in Ownership

IONIS PHARMACEUTICALS INC Filed Acc 0000874015-25-000059

EVP, Chief Development Officer sold 7,072 shares at $32.86 ($232,407)

  • EVP, Chief Development Officer acquired 18,901 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Geary Richard S · EVP, Chief Development Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2025-01-15 Exercise or conversion : show line 1 in the form +18,901 103,735 D
2025-01-16 Sale : show line 2 in the form −7,072 $32.86 $232,407 96,663 D
Open-market sales · 7,072 sh · avg $32.86 · $232,407

Table II: Derivative

3 lines
Date Transaction Shares Owned after D/I
2025-01-15 Grant or award : show line 3 in the form Performance Restricted Stock Units +22,000 64,801 D
2025-01-15 Grant or award : show line 4 in the form Restricted Stock Unit +33,000 79,625 D
2025-01-15 Exercise or conversion : show line 5 in the form Restricted Stock Unit −18,901 60,724 D
Loading xslF345X05/edgardoc.xml…